# Dutasteride + Tamsulosin

## Duodart 0.5/0.4mg

##### 

| TAH Drug Code      | ODUO                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Benign prostatic hyperplasia: Treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate                                                                                                                                                                                                                                                                                                                                |
| Dosing             | The recommended dose of Duodart is 1 capsule daily (0.5 mg / 0.4 mg). Duodart must always be taken with a glass of water, up to 30 minutes after a meal. It must never be taken on an empty stomach. Ideally, it should be taken at the same time of the day (this means with the same meal). The capsules should be swallowed whole and not chewed or opened, as contact with the capsule contents may result in irritation of the oropharyngeal mucosa. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Hypersensitivity (clinically significant) to dutasteride, tamsulosin, other 5-alpha-reductase inhibitors (eg, finasteride), or any component of the formulation; children; women of childbearing potential; pregnancy                                                                                                                                                                                                                                     |
| Adverse Effects    | 1% to 10%: Central nervous system: Dizziness (2%) Endocrine & metabolic: Decreased libido (5% to 6%), breast changes (3% to 5%, including enlargement, swelling, pain, tenderness, gynecomastia, nipple pain, nipple swelling) Genitourinary: Ejaculatory disorder (10% to 11%), impotence (8% to 10%) <1% (Limited to important or life-threatening): Prostate cancer (high-grade)                                                                       |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data â€“ Potential Toxicity(Mother)                                                                                                                                                                                                                                                                                                                                                                                                      |

